Elizabeth H Barnes - JoVE Visualize

Showing results (51-60 of 69) with videos related to

Pageof 7

Sort By:

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 5, 2019

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trialLauren R Olafson, Anna H Siddell, Kathryn M Field, et al.

Journal of the American Heart Association|October 25, 2013

Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyHarvey D White, John Simes, Ralph A H Stewart, et al.

The Lancet. Child & Adolescent Health|May 16, 2025

Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trialShihab Hameed, Elizabeth H Barnes, Julie Briody, et al.

Plos One|October 13, 2020

Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trialMohammad Alfelali, Elizabeth A Haworth, Osamah Barasheed, et al.

Neuro-Oncology|May 13, 2021

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU studyHao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.

BMJ Open|February 10, 2025

Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 gliomaKristen McParland, Eng-Siew Koh, Benjamin Kong, et al.

BMJ Open|September 14, 2022

Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastomaBenjamin Y Kong, Hao-Wen Sim, Elizabeth H Barnes, et al.

BMJ Open|April 13, 2023

Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trialSandra Hayes, Andreas Obermair, Linda Mileshkin, et al.

BMJ Supportive & Palliative Care|February 22, 2023

Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind studyMeera R Agar, Anna K Nowak, Elizabeth J Hovey, et al.

Brain, Behavior, and Immunity|January 10, 2021

Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: Transcriptomic data show common enriched innate immune pathwaysHannah F Jones, Velda X Han, Shrujna Patel, et al.

Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:

Pageof 7

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 5, 2019

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trialLauren R Olafson, Anna H Siddell, Kathryn M Field, et al.

Journal of the American Heart Association|October 25, 2013

Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease studyHarvey D White, John Simes, Ralph A H Stewart, et al.

The Lancet. Child & Adolescent Health|May 16, 2025

Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trialShihab Hameed, Elizabeth H Barnes, Julie Briody, et al.

Plos One|October 13, 2020

Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trialMohammad Alfelali, Elizabeth A Haworth, Osamah Barasheed, et al.

Neuro-Oncology|May 13, 2021

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU studyHao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.

BMJ Open|February 10, 2025

Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 gliomaKristen McParland, Eng-Siew Koh, Benjamin Kong, et al.

BMJ Open|September 14, 2022

Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastomaBenjamin Y Kong, Hao-Wen Sim, Elizabeth H Barnes, et al.

BMJ Open|April 13, 2023

Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trialSandra Hayes, Andreas Obermair, Linda Mileshkin, et al.

BMJ Supportive & Palliative Care|February 22, 2023

Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind studyMeera R Agar, Anna K Nowak, Elizabeth J Hovey, et al.

Brain, Behavior, and Immunity|January 10, 2021

Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: Transcriptomic data show common enriched innate immune pathwaysHannah F Jones, Velda X Han, Shrujna Patel, et al.

Pageof 7